A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Aug 25, 2026 - P3 | N=228 | Active, not recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
|